SAN FRANCISCO--(BUSINESS WIRE)--Penumbra, Inc., a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices, today announced that the results ...
Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results from its landmark STORM-PE randomized controlled trial. The study found that ...
Pairing a stent retriever with an aspiration system is not inferior to aspiration alone in patients with acute ischemic strokes caused by large-vessel occlusions (LVOs), according to the now-published ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Indigo ® System Lightning ...
Penumbra has benefited from renewed enthusiasm around the company's neuro and peripheral thrombectomy platforms, and the company recently launched the Lightning Flash. Management is making a big bet ...
European Multicenter Study Results Presented at Society of NeuroInterventional Surgery 12 th Annual Meeting SAN FRANCISCO, Penumbra, Inc., a global interventional therapies company that designs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback